SCOPUS 정보 검색 플랫폼

Volumn 9, Issue 15, 2004, Pages 625-627

Hitting the chemotherapy jackpot: Strategy, productivity and chemistry

(2) Westwell, Andrew D a Stevens, Malcolm F G a

a IMPERIAL CANCER RESEARCH FUND (United Kingdom)

Author keywords

Chemical Biology; differentiation strategies; Drug Discovery; druggability; gene expression based high throughput screening; human genome; Pharmaceutical Science; target validation

Indexed keywords

IMATINIB; SMALL INTERFERING RNA; THIAZOLE DERIVATIVE;

BIOTECHNOLOGY; CANCER COMBINATION CHEMOTHERAPY; CANCER RESEARCH; CHRONIC MYELOID LEUKEMIA; DNA MICROARRAY; DRUG EFFICACY; DRUG INDUSTRY; EDITORIAL; GENOMICS; HUMAN; TARGET CELL DESTRUCTION; VALIDATION PROCESS;

ANTINEOPLASTIC AGENTS; CHEMISTRY, PHARMACEUTICAL; GENOME, HUMAN; HUMANS;

EID: 3242814488 PISSN: 13596446 EISSN: None Source Type: Journal
DOI: 10.1016/S1359-6446(04)03162-9 Document Type: Editorial

Times cited : (11)

References (12)

1
- 1642354534
- Surviving the blockbuster syndrome
- Service R.F. Surviving the blockbuster syndrome. Science. 303:2004;1796-1799
- (2004) Science , vol.303 , pp. 1796-1799
- Service, R.F.¹

2
- 0036219647
- Translating basic cancer research into new cancer therapeutics
- Workman P., Kaye S.B. Translating basic cancer research into new cancer therapeutics. Trends Mol. Med. 8:2002;S1-S9
- (2002) Trends Mol. Med. , vol.8 , pp. 1-S9
- Workman, P.¹ Kaye, S.B.²

3
- 1842635467
- Target driven chemistry in drug discovery
- Eliseev A.V. Target driven chemistry in drug discovery. Drug Discov. Today. 9:2004;348-349
- (2004) Drug Discov. Today , vol.9 , pp. 348-349
- Eliseev, A.V.¹

4
- 0036216405
- STI571 (Gleevec™) as a paradigm for cancer therapy
- Druker B.J. STI571 (Gleevec™) as a paradigm for cancer therapy. Trends Mol. Med. 8:2002;S14-S18
- (2002) Trends Mol. Med. , vol.8 , pp. 14-S18
- Druker, B.J.¹

5
- 0034861199
- Fojo T. Novel_target.com. Oncologist. 6:2001;313-314
- (2001) Oncologist , vol.6 , pp. 313-314
- Fojo, T.¹

6
- 0037416141
- The small-molecule approach to biology
- Schreiber S.L. The small-molecule approach to biology. Chem. Eng. News. 81:2003;51-61
- (2003) Chem. Eng. News , vol.81 , pp. 51-61
- Schreiber, S.L.¹

7
- 0842274205
- Rediscovering the sweet spot in drug discovery
- Brown D., Superti-Furga G. Rediscovering the sweet spot in drug discovery. Drug Discov. Today. 8:2003;1067-1077
- (2003) Drug Discov. Today , vol.8 , pp. 1067-1077
- Brown, D.¹ Superti-Furga, G.²

8
- 1642602772
- Drug discovery in reverse
- Smith C. Drug discovery in reverse. Nature. 428:2004;227
- (2004) Nature , vol.428 , pp. 227
- Smith, C.¹

9
- 85089360332
- Obituary of Dr Paul Janssen (1926-2003)
- Lewi P. Obituary of Dr Paul Janssen (1926-2003). Drug Discov. Today. 9:2004;432-433
- (2004) Drug Discov. Today , vol.9 , pp. 432-433
- Lewi, P.¹

10
- 0036233675
- Developmental therapeutics program at the NCI: Molecular target and drug discovery process
- Monga M., Sausville E.A. Developmental therapeutics program at the NCI: molecular target and drug discovery process. Leukemia. 16:2002;520-526
- (2002) Leukemia , vol.16 , pp. 520-526
- Monga, M.¹ Sausville, E.A.²

11
- 1842484230
- The development of the antitumour benzothiazole prodrug, Phortress, as a clinical candidate
- Bradshaw T.D., Westwell A.D. The development of the antitumour benzothiazole prodrug, Phortress, as a clinical candidate. Curr. Med. Chem. 11:2004;1009-1021
- (2004) Curr. Med. Chem. , vol.11 , pp. 1009-1021
- Bradshaw, T.D.¹ Westwell, A.D.²

12
- 1442335997
- Gene-expression-based high-throughput screening (GE-HTS) and application to leukemia differentiation
- Stegmaier K., et al. Gene-expression-based high-throughput screening (GE-HTS) and application to leukemia differentiation. Nat. Genet. 36:2004;257-263
- (2004) Nat. Genet. , vol.36 , pp. 257-263
- Stegmaier, K.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.